Literature DB >> 7567281

Application of new sepsis definitions to evaluate outcome of pediatric patients with severe systemic infections.

X Sáez-Llorens1, S Vargas, F Guerra, L Coronado.   

Abstract

No published reports have stratified pediatric patients with systemic infections according to the new sepsis terminology guidelines. In addition little is known about the outcome of sepsis in developing countries. This large 12-year retrospective study evaluated the outcome of 815 infants and children with sepsis managed in a Latin American pediatric intensive care unit. Of these children 171 (21%) had sepsis, 497 (61%) had severe sepsis and 147 (18%) had septic shock. Multiorgan dysfunction was present in 120 (24%) and 77 (52%) patients with severe sepsis and septic shock, respectively. Infection was bacteriologically proved in 212 (26%) cases, with Staphylococcus aureus and Neisseria meningitidis being the most frequent responsible organisms. Three hundred nineteen (39%) patients died. Case-fatality rates were higher in patients with septic shock, multiorgan dysfunction, sepsis caused by Pseudomonas aeruginosa and meningococcemia than in those without these conditions. Although no difference in mortality was detected between culture-proved and culture-negative sepsis, more patients receiving an inappropriate antimicrobial agent died than those treated with an appropriate drug (53% vs. 34%, P = 0.012). We believe that with the use of the new terminology system a more reliable comparison of data from pediatric sepsis studies and of emerging immunomodulating therapeutic modalities can be achieved.

Entities:  

Mesh:

Year:  1995        PMID: 7567281     DOI: 10.1097/00006454-199507000-00001

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  16 in total

1.  Frequency of low-level bacteremia in children from birth to fifteen years of age.

Authors:  J A Kellogg; J P Manzella; D A Bankert
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Epidemiology and peculiarities of pediatric multiple organ dysfunction syndrome in New Delhi, India.

Authors:  Praveen Khilnani; Devajit Sarma; Jerry Zimmerman
Journal:  Intensive Care Med       Date:  2006-09-15       Impact factor: 17.440

Review 3.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

Review 4.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 5.  Epidemiology of Pediatric Septic Shock.

Authors:  Daniela Carla de Souza; Flávia Ribeiro Machado
Journal:  J Pediatr Intensive Care       Date:  2018-12-28

6.  Diagnosing and treating attentional difficulties: a nationwide survey.

Authors:  I McKenzie; C Wurr
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

7.  Capillary refill: prognostic value in Kenyan children.

Authors:  A Pamba; K Maitland
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

8.  Antibiotic use in Thailand: quantifying impact on blood culture yield and estimates of pneumococcal bacteremia incidence.

Authors:  Julia Rhodes; Joseph A Hyder; Leonard F Peruski; Cindy Fisher; Possawat Jorakate; Anek Kaewpan; Surang Dejsirilert; Somsak Thamthitiwat; Sonja J Olsen; Scott F Dowell; Somrak Chantra; Kittisak Tanwisaid; Susan A Maloney; Henry C Baggett
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 9.  Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians.

Authors:  Samson Gwer; Charles R J C Newton; James A Berkley
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

10.  Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: a case control study.

Authors:  Tonje Reier-Nilsen; Teresa Farstad; Britt Nakstad; Vigdis Lauvrak; Martin Steinbakk
Journal:  BMC Pediatr       Date:  2009-01-19       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.